Manipulation of isoprenoid biosynthesis as a possible therapeutic option in mevalonate kinase deficiency

Abstract

Our results indicate that manipulations of the isoprenoid biosynthesis pathway that promote the synthesis of nonsterol isoprenoids may provide an interesting therapeutic option for the treatment of MK deficiency.